Advanced Neuromonitoring and Emerging Technologies in Traumatic Brain Injury: Current Evidence, Clinical Applications, and Future Perspectives
DOI:
https://doi.org/10.64784/243Keywords:
traumatic brain injury, neurocritical care, multimodal neuromonitoring, intracranial pressure monitoring, brain tissue oxygen monitoring, cerebral microdialysis, advanced neuroimaging, diffusion tensor imaging, artificial intelligence, machine learning, precision medicine, neurosurgery, neuroprotection, cerebral perfusion, critical careAbstract
Traumatic brain injury (TBI) remains one of the leading causes of mortality and long-term neurological disability worldwide, representing a major challenge for emergency medicine, neurosurgery, radiology, and neurocritical care. In recent years, substantial advances have transformed traditional approaches to TBI management through the incorporation of multimodal neuromonitoring systems, advanced neuroimaging technologies, artificial intelligence, and personalized therapeutic strategies. This review examines current innovations in traumatic brain injury management, focusing on intracranial pressure monitoring, brain tissue oxygen monitoring, cerebral microdialysis, advanced magnetic resonance imaging techniques, machine learning applications, and contemporary neurosurgical interventions. Scientific evidence from international studies demonstrates that multimodal monitoring provides a more comprehensive assessment of cerebral physiology by integrating information related to perfusion, oxygenation, metabolism, and neurological function, facilitating earlier identification of secondary brain injury and supporting individualized treatment decisions. Likewise, advanced neuroimaging modalities such as diffusion tensor imaging, susceptibility-weighted imaging, perfusion imaging, and functional magnetic resonance imaging have improved diagnostic precision and prognostic evaluation. Artificial intelligence has emerged as a promising tool for data integration, predictive analytics, lesion characterization, and clinical decision support. Collectively, these innovations are contributing to the evolution of neurocritical care toward precision medicine models that prioritize personalized monitoring and targeted therapeutic interventions. Although challenges related to accessibility, implementation, infrastructure, and training remain, particularly in low- and middle-income countries, the available evidence suggests that the integration of advanced monitoring technologies and data-driven clinical strategies may significantly improve neurological outcomes, reduce secondary injury, and enhance quality of life among patients affected by traumatic brain injury. Continued research, multidisciplinary collaboration, and equitable adoption of emerging technologies will be essential for advancing the future of neurotrauma care worldwide.
References
[1] N. Carney et al., “Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition,” Neurosurgery, vol. 80, no. 1, pp. 6–15, 2017.
[2] G. W. J. Hawryluk et al., “A management algorithm for patients with intracranial pressure monitoring: The Seattle International Severe Traumatic Brain Injury Consensus Conference,” Intensive Care Medicine, vol. 45, pp. 1783–1794, 2019.
[3] R. M. Chesnut et al., “A trial of intracranial-pressure monitoring in traumatic brain injury,” New England Journal of Medicine, vol. 367, no. 26, pp. 2471–2481, 2012.
[4] J.-F. Payen et al., “Intracranial pressure monitoring with and without brain tissue oxygen pressure monitoring for severe traumatic brain injury in France (OXY-TC),” The Lancet Neurology, vol. 22, no. 11, pp. 1005–1014, 2023.
[5] F. Bernard et al., “Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-3 trial,” BMJ Open, vol. 12, e060188, 2022.
[6] T. Jeffcote et al., “Brain tissue oxygen monitoring in moderate-to-severe traumatic brain injury,” Current Opinion in Critical Care, 2024.
[7] K. L. H. Carpenter, P. J. Hutchinson, and M. Czosnyka, “Advanced monitoring in traumatic brain injury: Microdialysis,” Current Opinion in Critical Care, vol. 23, no. 2, pp. 103–109, 2017.
[8] S. Y. Bögli et al., “Unlocking the potential of high-resolution multimodality neuromonitoring for traumatic brain injury management,” Critical Care, 2025.
[9] A. I. R. Maas et al., “Traumatic brain injury: Progress and challenges in prevention, clinical care, and research,” The Lancet Neurology, vol. 21, no. 11, pp. 1004–1060, 2022.
[10] E. W. Steyerberg et al., “Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI,” The Lancet Neurology, vol. 18, no. 10, pp. 923–934, 2019.
[11] C. A. I. Åkerlund et al., “Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit,” The Lancet Neurology, 2024.
[12] I. R. A. Retel Helmrich et al., “Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury,” The Lancet Neurology, vol. 21, no. 9, pp. 792–802, 2022.
[13] A. J. Tsiouris and A. Sanelli, “Neuroimaging update on traumatic brain injury,” Neuroimaging Clinics of North America, 2024.
[14] L. Hu et al., “Advanced neuroimaging role in traumatic brain injury,” Frontiers in Neuroscience, vol. 16, 2022.
[15] M. E. Shenton et al., “A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury,” Brain Imaging and Behavior, vol. 6, pp. 137–192, 2012.
[16] P. J. Hutchinson et al., “Trial of decompressive craniectomy for traumatic intracranial hypertension,” New England Journal of Medicine, vol. 375, pp. 1119–1130, 2016.
[17] D. J. Cooper et al., “Decompressive craniectomy in diffuse traumatic brain injury,” New England Journal of Medicine, vol. 364, pp. 1493–1502, 2011.
[18] CRASH-3 Trial Collaborators, “Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury,” The Lancet, vol. 394, no. 10210, pp. 1713–1723, 2019.
[19] E. Ortiz-Prado et al., “A nationwide study of incidence and mortality due to traumatic brain injury in Ecuador (2004–2016),” Neuroepidemiology, vol. 54, no. 1, pp. 33–44, 2020.
[20] P. Puvanachandra and A. A. Hyder, “Traumatic brain injury in Latin America and the Caribbean: A call for research,” Salud Pública de México, vol. 50, suppl. 1, pp. S3–S5, 2008.
